Amphastar Pharmaceuticals, Inc. has reported 26% growth in its fourth quarter sales to $120.9m, up from $95.9m reported in the prior-year period. For the full year of 2021, turnover was also up by a quarter at $437.8m.
The company credited the performance of Primatene Mist (epinephrine) for its double-digit growth, with the drug’s sales increase of 60%...




